A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Endocrinology

• Publication date

  1996-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/ENDO.137.8.8754741PMID 8754741
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3).

  1995cited by this paper
• Insulin-like growth factors and their binding proteins: biological actions.

  1995influential reference
• Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells.

  1994cited by this paper
• Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma.

  1994cited by this paper
• Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures.

  1994cited by this paper
• Biochemical analysis of prostate specific antigen-proteolyzed insulin-like growth factor binding protein-3.

  1994cited by this paper
• In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells.

  1994cited by this paper
• Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition.

  1993cited by this paper
• Evidence that limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3) occurs in the normal state outside of the bloodstream.

  1993cited by this paper
• Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6.

  1993cited by this paper
• Insulin-like growth factor binding proteins.

  1993cited by this paper
• Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells.

  1993cited by this paper
• Involvement of the plasmin system in dissociation of the insulin-like growth factor-binding protein complex.

  1992cited by this paper
• Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: discrepancies between radioimmunoassay and ligand blotting.

  1992cited by this paper
• Insulin‐like growth factor binding protein (IGFBP‐3), an inhibitor of serum growth factors other than IGF‐I and ‐II

  1992cited by this paper
• Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma.

  1992cited by this paper
• Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism.

  1992cited by this paper
• Purification from human cerebrospinal fluid of insulin-like growth factor binding proteins (IGFBPs). Isolation of IGFBP-2, an altered form of IGFBP-3 and a new IGFBP species.

  1991cited by this paper
• Intact but not truncated insulin-like growth factor binding protein-3 (IGFBP-3) blocks IGF I-induced stimulation of osteoblasts: control of IGF signalling to bone cells by IGFBP-3-specific proteolysis?

  1991cited by this paper
• Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I.

  1991cited by this paper
• Purification and characterization of human recombinant insulin-like growth factor binding protein 3 expressed in Chinese hamster ovary cells.

  1991cited by this paper
• The plasminogen activator/plasmin system.

  1991cited by this paper
• Isolation from adult human serum of four insulin-like growth factor (IGF) binding proteins and molecular cloning of one of them that is increased by IGF I administration and in extrapancreatic tumor hypoglycemia.

  1990cited by this paper
• Structural and biological characterization of bovine insulin-like growth factor binding protein-3.

  1990cited by this paper
• Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity.

  1990cited by this paper
• Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy.

  1990cited by this paper
• Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts.

  1988cited by this paper
• Insulin-like growth factor (IGF) and IGF-binding proteins: comparison of human serum and lymph.

  1988cited by this paper
• Cell-associated plasminogen activation: regulation and physiological functions.

  1988cited by this paper
• Heterogeneity of insulin-like growth factor binding proteins and relationships between structure and affinity. 1. Circulating forms in man.

  1987cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Paracrine factors of human fetal MSCs inhibit liver cancer growth through reduced activation of IGF-1R/PI3K/Akt signaling.

  2015cites this paper
• Targeting insulin-like growth factor-I and insulin-like growth factor-binding protein-3 signaling pathways. A novel therapeutic approach for asthma.

  2014cites this paper
• Activation of various downstream signaling molecules by IGFBP-3.

  2014cites this paper
• Signal Transduction Pathways Mediated by Secreted and Non-Secreted Forms of Intact Insulin-Like Growth Factor Binding Protein-3 ( IGFBP-3 ) and Its 197 N-Terminal Fragment in PC-3 Human Prostate Cancer Cells *

  2013cites this paper
• Signal Transduction Pathways Mediated by Secreted and Non-secreted Forms of intact Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) and its 1-97 N-terminal Fragment in PC-3 Human Prostate Cancer Cells.

  2013cites this paper
• Insulin-Like Growth Factors IGFBP7 Binds to the IGF-1 Receptor and Blocks Its Activation by `

  2013cites this paper
• IGF System in Cancer IGF System and Cancer Risk

  2013cites this paper
• The insulin-like growth factor system in cancer.

  2012cites this paper
• Prednisolone reduces the ability of serum to activate the IGF1 receptor in vitro without affecting circulating total or free IGF1.

  2012cites this paper
• Colocalization and identification of interaction sites between IGFBP-3 and GalNAc-T14.

  2012cites this paper
• IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways

  2012cites this paper
• IGFBP7 Binds to the IGF-1 Receptor and Blocks Its Activation by Insulin-Like Growth Factors

  2012cites this paper
• Normal and Aberrant Growth

  2011cites this paper
• Human IGF binding protein-3 overexpression impairs glucose regulation in mice via an inhibition of insulin secretion.

  2011cites this paper
• Acute regulation of IGF-I by alterations in post-exercise macronutrients

  2011cites this paper
• Validation of functional insulin-like growth factor binding protein-3 measurement by a ligand immunoassay.

  2010cites this paper
• Nuclear export and mitochondrial and endoplasmic reticulum localization of IGF-binding protein 3 regulate its apoptotic properties.

  2010cites this paper
• Perspectives in mammalian IGFBP-3 biology: local vs. systemic action.

  2009cites this paper
• Acute Regulation Of Igf-1 By Differential Binding Protein Expression, Inhibition, And Proteolysis: 2411

  2009cites this paper
• Unraveling insulin-like growth factor binding protein-3 actions in human disease.

  2009cites this paper
• IGFBP-1 protease activity and IGFBP-1 fragments in a patient with multiple myeloma.

  2009influential citation
• IGF-I binding to the IGF-I receptor is affected by contaminants in commercial BSA: the contaminants are proteins with IGF-I binding properties.

  2008cites this paper
• Molecular regulation of insulin-like growth factor binding protein-3 and its role in ribotoxic stress-induced apoptosis

  2008cites this paper
• An N-terminal fragment of insulin-like growth factor binding protein-3 (IGFBP-3) induces apoptosis in human prostate cancer cells in an IGF-independent manner.

  2008influential citation
• Intact and total insulin-like growth factor-binding protein-3 (IGFBP-3) levels in relation to breast cancer risk factors: a cross-sectional study

  2008cites this paper
• Interactions between IGFBP-3 and Nuclear Receptors in Prostate Cancer Apoptosis

  2008cites this paper
• IGF Binding Proteins (IGFBPs) and Regulation of Breast Cancer Biology

  2008cites this paper
• Various components of the insulin‐like growth factor system in tumor tissue, cerebrospinal fluid and peripheral blood of pediatric medulloblastoma and ependymoma patients

  2008cites this paper
• Cerebrospinal fluid and serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in patients with severe head injury A¤ir kafa travmali hastalarda beyin omurilik sivisi ve serum IGF-1 ve IGFBP-3 deerleri

  2007cites this paper
• Ağır kafa travmalı hastalarda beyin omurilik sıvısı ve serum IGF-1 ve IGFBP-3 değerleri

  2007cites this paper
• Proteomics Demonstration That Normal Breast Epithelial Cells Can Induce Apoptosis of Breast Cancer Cells through Insulin-like Growth Factor-binding Protein-3 and Maspin*

  2007cites this paper
• N-Acetylgalactosaminyltransferase 14, a novel insulin-like growth factor binding protein-3 binding partner.

  2007cites this paper
• Cerebrospinal fluid and serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in patients with severe head injury.

  2007cites this paper
• Insulin-like growth factor binding proteins and breast cancer

  2007cites this paper
• Induction of apoptosis by the 16-kDa amino-terminal fragment of the insulin-like growth factor binding protein 3 in human colonic carcinoma cells.

  2006cites this paper
• The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.

  2006cites this paper
• Insulin-like growth factors and their binding proteins in prostate cancer: cause or consequence?

  2006cites this paper
• Molekulare Mechanismen der Wachstumswirkung des IGF-Systems

  2006cites this paper
• Mining the acute respiratory distress syndrome proteome: identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injury.

  2006cites this paper
• THE NUCLEAR ACTIONS OF IGFBP-3

  2006cites this paper
• Reduced Collagen Degradation in Polytraumas with Traumatic Brain Injury Causes Enhanced Osteogenesis

  2006cites this paper
• Structural basis for the regulation of insulin-like growth factors by IGF binding proteins.

  2006cites this paper
• The aminoterminal insulin-like growth factor (IGF) binding domain of IGF binding protein-3 cannot be functionally substituted by the structurally homologous domain of CCN3.

  2006cites this paper
• Insulin-like Growth Factor-I and Its Binding Proteins: Regulation of Secretion and Mechanism of Action at the Receptor Level

  2006cites this paper
• THESIS FOR THE DEGREE OF PH.D. EFFECTS OF ACUTE PHASE REACTION ON THE REGULATION OF THE IGF SYSTEM IN LIVER OF THE RAT

  2005cites this paper
• Signaling cross-talk between IGF-binding protein-3 and transforming growth factor-(beta) in mesenchymal chondroprogenitor cell growth.

  2005cites this paper
• Structural basis for the regulation of insulin-like growth factors (IGFs) by IGF binding proteins (IGFBPs)

  2005cites this paper
• REGULATION OF HEPATIC ALS AND IGFBP-1 EXPRESSION

  2005cites this paper
• Identifizierung und Charakterisierung von neuen Proteinen, die mit den humanen Insulin-ähnlichen Wachstumsfaktoren (IGF) und IGF-Bindungsproteinen interagieren

  2005cites this paper
• Biochemical Studies on IGF and IGF-Binding Proteins Interactions & Structural Investigations on the SH3 Domain of Crk-associated Tyrosine Kinase Substrate p130cas (CAS)

  2005cites this paper
• The role of the IGF system in somatic cell and oocyte development during early bovine follicular development

  2005cites this paper
• Pregnancy‐associated plasma protein‐A proteolytic activity in rat vertebral cell cultures: Stimulation by dexamethasone–a potential mechanism for glucocorticoid regulation of osteoprogenitor proliferation and differentiation

  2005cites this paper
• The insulin-like growth factor system : Effects of circulating proteases

  2005cites this paper
• The insulin-like growth factor system: IGFs, IGF-binding proteins and IGFBP-proteases.

  2005cites this paper
• Diversity of human insulin-like growth factor (IGF) binding protein-2 fragments in plasma: primary structure, IGF-binding properties, and disulfide bonding pattern.

  2005cites this paper
• Overexpression of gly56/gly80/gly81-mutant insulin-like growth factor-binding protein-3 in transgenic mice.

  2005cites this paper
• The effects of insulin-like growth factor binding protein-3 (IGFBP-3) on T47D breast cancer cells enriched for IGFBP-3 binding sites

  2004cites this paper
• Epidermal Growth Factor Receptor Regulates Aberrant Expression of Insulin-Like Growth Factor-Binding Protein 3

  2004influential citation
• Insulin-Like Growth Factor-Binding Protein 3 Induces Caspase-Dependent Apoptosis through a Death Receptor-Mediated Pathway in MCF-7 Human Breast Cancer Cells

  2004cites this paper
• Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding.

  2004influential citation
• Tissue Transglutaminase Has Intrinsic Kinase Activity

  2004cites this paper
• Free insulin-like growth factors -- measurements and relationships to growth hormone secretion and glucose homeostasis.

  2004cites this paper
• Insulin-like growth factor binding protein-3 is a novel mediator of apoptosis in insulin-secreting cells.

  2004cites this paper
• Up date on IGFBP-4: regulation of IGFBP-4 levels and functions, in vitro and in vivo.

  2004cites this paper
• An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis.

  2004cites this paper
• HUMAN BREAST CANCER CELLS

  2004cites this paper
• What's new in the IGF-binding proteins?

  2004cites this paper
• Receptor-Mediated Pathway in MCF-7 Human Breast Cancer Caspase-Dependent Apoptosis through a Death Insulin-Like Growth Factor-Binding Protein 3 Induces

  2004cites this paper
• Insulin-Like Growth Factor Binding Proteins (IGFBPs) in Breast Cancer

  2004cites this paper
• Insulin-Like Growth Factor Binding Protein-3 Interacts with Autocrine Motility Factor/Phosphoglucose Isomerase (AMF/PGI) and Inhibits the AMF/PGI Function

  2004cites this paper
• IGF and Nutrition in Health and Disease

  2004cites this paper
• Overview and Molecular Aspects of the Insulin-Like Growth Factor System

  2004cites this paper
• Regulation of insulin-like growth factor (IGF)-I action by matrix metalloproteinase-3 involves selective disruption of IGF-I/IGF-binding protein-3 complexes.

  2004cites this paper
• Epidermal homeostasis: the role of the growth hormone and insulin-like growth factor systems.

  2003cites this paper
• Phosphorylation of insulin-like growth factor (IGF) binding protein-3 by breast cancer cell membranes enhances IGF-I binding.

  2003cites this paper
• Expression of IGFBP-3 by human retinal endothelial cell cultures: IGFBP-3 involvement in growth inhibition and apoptosis.

  2003cites this paper
• Amino- and carboxyl-terminal fragments of insulin-like growth factor (IGF) binding protein-3 cooperate to bind IGFs with high affinity and inhibit IGF receptor interactions.

  2003cites this paper
• Interaction of insulin-like growth factor binding protein-3 with latent transforming growth factor-beta binding protein-1

  2003cites this paper
• The Insulin-Like Growth Factor System

  2003cites this paper
• The Insulin-Like Growth Factor (IGF) Family and Breast Cancer

  2003cites this paper
• Actions of IGFBP on Epithelial Cancer Cells: Potential for New Therapeutic Targets

  2003cites this paper
• Deregulation of the IGF axis in cancer: epidemiological evidence and potential therapeutic interventions.

  2003cites this paper
• IGFBPs and Breast Cancer

  2003cites this paper
• BEYOND CARRIER PROTEINS Nuclear effects: unexpected intracellular actions of insulin-like growth factor binding protein-3

  2002cites this paper
• Cellular actions of the insulin-like growth factor binding proteins.

  2002cites this paper
• Binding properties of insulin-like growth factor binding protein-3 (IGFBP-3), IGFBP-3 N- and C-terminal fragments, and structurally related proteins mac25 and connective tissue growth factor measured using a biosensor.

  2002cites this paper
• Nuclear effects: unexpected intracellular actions of insulin-like growth factor binding protein-3.

  2002cites this paper
• Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor.

  2002cites this paper
• Insulin-like Growth Factor (IGF)-binding Protein-3 Mutants That Do Not Bind IGF-I or IGF-II Stimulate Apoptosis in Human Prostate Cancer Cells*

  2002cites this paper
• Circulating levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in patients with severe head injury.

  2002cites this paper
• Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.

  2002cites this paper
• Enhanced expression of insulin-like growth factor binding protein-3 sensitizes the growth inhibitory effect of anticancer drugs in gastric cancer cells.

  2002cites this paper
• Expression of components of the IGF signalling system in childhood acute lymphoblastic leukaemia

  2002cites this paper
• The amino-terminal region of insulin-like growth factor binding protein-3, (1-95)IGFBP-3, induces apoptosis of MCF-7 breast carcinoma cells.

  2002cites this paper
• Biological significance of insulin-like growth factor binding proteins

  2002cites this paper
• The IGFBP-3 mRNA and protein levels are IGF-I-dependent and GH-independent in MG-63 human osteosarcoma cells.

  2001cites this paper
• Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) binds to fibronectin (FN): demonstration of IGF-I/IGFBP-3/fn ternary complexes in human plasma.

  2001cites this paper
• The changes of IGF binding proteins after rhGH administration to patients totally dependent on parenteral nutrition.

  2001cites this paper
• IGFBP-3 and apoptosis—a licence to kill?

  2001cites this paper
• No Influence of Prednisolone on IGFBP-3 Proteolysis in Healthy Young Men

  2001cites this paper